Moreover, Jun and Fos protein stability and turnover could be affected (as described for a stabilizing point mutation affecting cJun-Ser243 [53]), i.e., effects potentially contributing to the discrepancy observed between jun/fos mRNA and protein expression in the SM from RA patients [54]. This evidence concerns the gene FOS and rheumatoid arthritis.